You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Imyanitov E, Marchetti C, Sokolenko A, et al
2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy
International Journal of Gynecologic Cancer 2022;32:A310.